<A HREF="http://sc.ifeng.com/event.ng/Type=click&FlightID=21821&AdID=21594&TargetID=304&Segments=1,160,262,871&Targets=882,196,304,811&Values=34,46,51,81,100,110,204,228,238,263,305,583&RawValues=&Redirect=http://ad.cn.doubleclick.net/click;h=v2|3AFC|0|0|%2a|w;214677492;0-0;0;36519659;31-1|1;21717145|21735035|1;;%3fhttp://www-900.ibm.com/innovation/cn/healthcare/index.shtml?ca=apch_sp-20090511&me=banner&met=sp&re=ifeng&s_tact=chspb002&cm_mmc=apch_sp-20090511-chspb002-_-b-_-sp-_-ifeng" target="_blank"><IMG SRC="http://img.ifeng.com/tres/recommend/client/ibm2007/090512-ibm_finance-950x90.swf" WIDTH=950 HEIGHT=90 BORDER=0></A>

凤凰财经 > 港股 > 综合损益表 > 中生北控生 (08247.HK)
港股代码：

08247 中生北控生物科技股份有限公司 - H股

综合损益表
单位: 人民币 (元) 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
营业额  200,591,000.00  174,672,000.00  147,806,000.00  135,432,000.00  121,989,000.00
除税前盈利/(亏损)  31,079,000.00  29,124,000.00  27,730,000.00  30,447,000.00  29,961,000.00
税项  -5,156,000.00  -7,126,000.00  -6,667,000.00  -3,921,000.00  -4,053,000.00
除税后盈利/(亏损)  25,923,000.00  21,998,000.00  21,063,000.00  26,526,000.00  25,908,000.00
少数股东权益  -1,968,000.00  -2,069,000.00  -912,000.00  2,174,000.00  2,074,000.00
股东应占盈利/(亏损)  23,955,000.00  19,929,000.00  20,151,000.00  24,352,000.00  23,834,000.00
股息   10,002,000.00   10,002,000.00   10,002,000.00   10,002,000.00   33,490,000.00
除税及股息后盈利/(亏损)  13,953,000.00  9,927,000.00  10,149,000.00  14,350,000.00  -9,656,000.00
基本  24.00  20.00  20.00  35.00  34.00
摊薄  --  --  --  --  --
销售成本  65,248,000.00  62,087,000.00  50,387,000.00  40,862,000.00  33,582,000.00
折旧   12,499,000.00   10,784,000.00   8,411,000.00   3,861,000.00   3,010,000.00
利息费用/融资成本   5,578,000.00   6,022,000.00   3,754,000.00   475,000.00   24,000.00
毛利/(亏损)  135,343,000.00  112,585,000.00  97,419,000.00  94,570,000.00  88,407,000.00
经营盈利/(亏损)  36,973,000.00  35,778,000.00  31,484,000.00  30,922,000.00  29,985,000.00